
@IMI_JU project uniting 6 in vitro diagnostic companies with 20 non-industry partners to combat #AMR through #diagnostics to improve outcomes for patients
Joined July 2019
- Tweets237
- Following261
- Followers362
- Likes392
VALUE-Dx retweeted
Again, could not agree more. Innovation in #AMR #diagnostics should be patient centric. @SMalhotraKumar #ESCMIDGlobal2024 @ESCMID @ValueDx
VALUE-Dx retweeted
'We need high quality, strong data to tackle #AMR and it all starts with #diagnostics and with the scientists developing them' Lothar Wieler @mikrowie. So true and could not have said it better @longitude_prize @ValueDx @FINDdx @DosaDx @GLGAMR @GlobalAMRHub #ECCMID2023
VALUE-Dx retweeted
Would you take part in a #vaccine trial? Tell us why or why not in this 10-minute, anonymous survey to help us improve future #clinicaltrial participation, develop vaccines faster & safer, and protect our community against #COVID19 ➡️ bit.ly/3GLjMtp @vaccelerate_eu
VALUE-Dx retweeted

ESCMID@ESCMID3 Jan 2023
🇨🇭
SwitzerlandConnected via Switzerland App StoreAccount-level information, not a live location or per-post device.
ESCMID is supporter of the @ValueDx project. Be sure to take part in their survey on user requirements for patient management of community acquired respiratory tract infections (CA-ARTI) in a community setting until 8 January 2023.
Participate here: ow.ly/eWX350M46hB
VALUE-Dx retweeted

ESCMID@ESCMID5 Sep 2022
🇨🇭
SwitzerlandConnected via Switzerland App StoreAccount-level information, not a live location or per-post device.
@ESCMID Immediate Past President Maurizio Sanguinetti just gave an interesting talk about rapid diagnostics for #pneumonia infections acquired in emergency rooms at #ERSInternationalCongress2022. Session about the @ValueDx consortium perspective on new diagnostics to fight AMR.
VALUE-Dx retweeted
Great teamwork @ValueDx shared yesterday #ECCMID2022 on the impact of rapid #Diagnostics in CA-#respiratoryTractInfections Symposium co-organized @escmid @EuroRespSoc
Learn more about the project in value-dx.eu/
If you missed please find in eccmid.org/online_platform/
VALUE-Dx retweeted
New data from the #GRAMPaper shows that 1.27 million deaths were caused by #AMR in 2019. It’s time to act against this global health threat. Learn more: bit.ly/3nBEvas #AMRSOS
VALUE-Dx retweeted
In March 2021 @ECRAID-Base officially commenced. Take a look back at where it all started and the importance of the #ECRAID project. Read about #ECRAID-Base here 👉 cutt.ly/tYed52n #Epidemics #AMR #clinicaltrials @PREPARE_EUROPE @EU_Commission @EU_H2020 @IMI_JU @Moedas
VALUE-Dx retweeted
It's #WorldAntimicrobialAwarenessWeek 💊! #Antibioticresistance can affect anyone, of any age, in any country. We asked our colleagues to share their opinions about #WAAW21 and #AMR. @WHO @Ecraid @IMI_JU @EFPIA @ESCMID @IenI_UMCUtrecht @crisprat2010
VALUE-Dx retweeted
What happens if Antibiotics stop working?
#AntimicrobialResistance already presents a serious social & economic burden in the EU. 18 November is European Antibiotics Awareness Day.
More on the EU Action on #AMR⤵
europa.eu/!nx79qH
#EAAD #KeepAntibioticsWorking
VALUE-Dx retweeted
When doctors feel sure a patient’s symptoms are caused by a bacterial infection, #antibiotics are often prescribed promptly & confidently. When certainty is low, rapid tests are a worthy investment for them...and for society - @ValueDx
#IMICarryTheTorch
bit.ly/3uNCeLE
VALUE-Dx retweeted
Again exciting European qualitative research times ahead of us!! Just had our kick of meeting and training for our process evaluation of a very challenging European trial on diagnostics in primary care! #AMR #antibiotics @marta_wanat @hoste_melanie @SKGTonkinCrine @ValueDx – at Knokke-Heist, Belgium
VALUE-Dx retweeted
Congratulations to our Coordinator @ProfHGoossens
who received the @ESCMID Award for Excellence 2020 in Clinical Microbiology and Infectious Diseases! recover-europe.eu/prof-herma… @EU_Commission @H2020Projects #COVID19
VALUE-Dx retweeted
1 Honored to receive the Award for Excellence 2020 by @ESCMID. #Research and #education in clinical microbiology and ID are essential, as the #COVID19 pandemic showed. I look forward to the next phase in which we work towards the sustainable clinical research organisation @ECRAID
VALUE-Dx retweeted
COMBACTE's LAB-Net will serve as Central #Laboratory for a #Microbiology-Biomarker study in 4 long term care facilities enrolling adult #patients for the PRUDENCE #trial. LAB-Net
will provide materials to collect, process & store samples combacte.com/news/lab-net-ce… @IMI_JU @ValueDx
VALUE-Dx retweeted
The virtual Point Prevalence Survey training has started! Objective of today is to present the two main surveillance tools available to measure antimicrobial use in a hospital setting, the WHO-PPS and Global-PPS, and how to apply them in practice. @THETlinks @CW_Pharmacists @WHO
#CwPAMS Virtual Antimicrobial Point Prevalence Survey Training has commenced. Led by @THETlinks and @CW_Pharmacists in collaboration with @zarbp002 (WHO-PPS) & @GlobalPPS_comm. Great to have more than 200 participants online with us
VALUE-Dx retweeted
COMBACTE's LAB-Net will serve as a Central #Laboratory👨🔬 🔬for a Microbiology-Biomarker #study in four long term care facilities enrolling adult #patients for @ValueDx's PRUDENCE trial. Read more ➡️ combacte.com/news/lab-net-ce… @MedMicroLab_UA @efpia @IMI_JU
VALUE-Dx retweeted
Very much looking forward to speaking today on #AMR #RapidDiagnostics at yet another great @AmrInsights event and lots of new contacts and opportunities from the expected large turnout virtual-amr-innovation-missi… @ValueDx @DosaDx @JPIAMR @longitude_prize @M_van_Dongen
VALUE-Dx retweeted
Read the interview of the Communications Managers @dpazzola and @Esther_Kok_ based at @MedMicroLab_UA on the importance of science #communication. @UAntwerpen @vaxinfectio @COMBACTE @RECOVER_EUROPE @PREPARE_EUROPE @ValueDx @GlobalPPS_comm @ECRAID
What is the difference between #communication & #SciComms? And what has been the impact of #COVID19? In this 2nd blog Communication Managers @dpazzola & @Esther_Kok_ share their insight. Read how they master the art of project #comms: 👉combacte.com/news/communicat… @UAntwerpen @IMI_JU
VALUE-Dx retweeted
Did you know?💊
Up to 5⃣0⃣% of all antimicrobial use in European hospitals may be unnecessary or inappropriate, which might lead to #AntimicrobialResistance
More: europa.eu/!nx79qH
⤵⤵⤵
































